Trials
Under-served groups remain underserved as eligibility criteria routinely exclude them from breast cancer trials
[ad_1]
Objectives:
Under-served groups are populations unrepresented or disengaged from medical research or ser...
Looking at race and ethnicity in clinical trials
[ad_1]
In order to provide accurate results regarding the safety and efficacy of drugs and devices being tested through clinical trials, a divers...
Eligibility Criteria Perpetuate Disparities in Enrollment and Participation of Black Patients in Pancreatic Cancer Clinical Trials
[ad_1]
INTRODUCTION
Section:
ChooseTop of pageAbstractINTRODUCTION <<METHODSRESULTSDISCUSSIONREFERENCES
Clinical trials investigating ...
Reporting of Race and Ethnicity in Pediatric Trials Increased from 2011-2020
[ad_1]
A new investigation revealed that the number of published pediatric clinical trials that reported participant race and ethnicity increased...
Black, Hispanic Patients Underrepresented in Trials Supporting Guidelines for Endometrial Cancer
[ad_1]
Black and Hispanic patients are underrepresented in the clinical trials used to develop the National Comprehensive Cancer Network (NCCN) t...
Black, Hispanic Patients Underrepresented in Clinical Trials Cited in NCCN Guidelines for Endometrial Cancer Systemic Therapy Regimens
[ad_1]
Although poorer prognoses are common for all patients with advanced and recurrent endometrial cancers, minority populations are disproporti...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
